Physician

Ammar Hatab, M.D.

According to 2025 Medicare claims, Ammar Hatab, M.D. (NPI: 1760631741) practices allergy/immunology in the Tampa, FL market, with the plurality of this provider's patient population coming from Hillsborough, FL. This provider's primary affiliated billing organization is AAIA- TAMPA BAY LLC (NPI: 1730198037; TIN: 65-0596228) and primary practice location at 33618-2048.

Hatab's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 205 traditional Medicare patients, billed 7,257 HCPCS/CPT codes, and received $94,445 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 1,881 prescription claims across 253 beneficiaries totaling $905,192 in drug costs, led by Tezspire (Tezepelumab-Ekko). DME data shows 133 claims. Open Payments data shows 110 records totaling $2,727. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing started with an early spike, then settled into a lower baseline, moving from $224,573 to $94,445. In contrast, Part D prescription costs have moved from a lower plateau to a higher plateau, from $237,214 to $905,192. For DME billing, this smaller-volume category rose steadily, from $2,062 to $3,320.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$112K$225K2015 Medicare payment: $224,573 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $24,701 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $29,802 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $38,573 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $50,968 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $77,213 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $77,700 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $86,071 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $94,445 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151509,658$224,573
2016N/RN/RN/R
2017461,739$24,701
2018522,042$29,802
20191002,984$38,573
2020993,677$50,968
20212215,214$77,213
20222305,617$77,700
20232016,441$86,071
20242057,257$94,445

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$453K$905K2015 Drug cost: $237,214 (USD; Tot_Drug_Cst)2016 Drug cost: $132,293 (USD; Tot_Drug_Cst)2017 Drug cost: $125,818 (USD; Tot_Drug_Cst)2018 Drug cost: $154,723 (USD; Tot_Drug_Cst)2019 Drug cost: $292,675 (USD; Tot_Drug_Cst)2020 Drug cost: $495,277 (USD; Tot_Drug_Cst)2021 Drug cost: $490,264 (USD; Tot_Drug_Cst)2022 Drug cost: $644,936 (USD; Tot_Drug_Cst)2023 Drug cost: $688,517 (USD; Tot_Drug_Cst)2024 Drug cost: $905,192 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151731,477$237,214
2016130694$132,293
201799445$125,818
2018100645$154,723
2019204981$292,675
20202111,555$495,277
20212451,638$490,264
20222862,014$644,936
20232641,817$688,517
20242531,881$905,192

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$304K$609K2015 Medicare payment: $122,748 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $89,429 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $44,785 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $652 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $160,422 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $233,074 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $346,529 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $608,680 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $352,034 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R59$122,748
2016N/R35$89,429
2017N/R44$44,785
2018N/RN/RN/R
2019N/R14$652
2020N/R105$160,422
2021N/R132$233,074
2022N/R184$346,529
2023N/R313$608,680
2024N/R133$352,034

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more3434$115
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more132275$87
94010Test to measure expiratory airflow and volume107715$19
95165Professional service for preparation and provision of 1 or more antigens972,142$10
95117Professional service for multiple injections of allergen891,175$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
TezspireTezepelumab-Ekko631,764$269,234
XolairOmalizumab752,100$192,996
Dupixent SyringeDupilumab20462$75,350
NucalaMepolizumab16560$74,591
Trelegy ElliptaFluticasone/Umeclidin/Vilanter1123,510$71,161

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
J1555Injection, immune globulin (cuvitru), 100 mgNN/R34$238,058
J1559Injection, immune globulin (hizentra), 100 mgNN/R14$110,742
A4221Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)NN/R38$2,462
K0552Supplies for external non-insulin drug infusion pump, syringe type cartridge, sterile, eachNN/R47$771

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.110$2,727AstraZeneca Pharmaceuticals LP
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Ammar Hatab, M.D.?

Tedicare shows public-source Medicare data for Ammar Hatab, M.D. (NPI 1760631741), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ammar Hatab, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ammar Hatab, M.D.?

Ammar Hatab, M.D. is linked to AAIA- TAMPA BAY LLC (billing NPI 1730198037) in the available physician profile data.

Does Ammar Hatab, M.D. have Open Payments data?

Ammar Hatab, M.D. has 110 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.